Irina Dumitrescu1,2, Minne Casteels3,4, Kristel De Vliegher3, Tinne Dilles5. 1. Department of Nursing Science and Midwifery, Centre For Research and Innovation in Care (CRIC), Nurse and Pharmaceutical Care (NuPhaC), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. irina.dumitrescu@vlaanderen.wgk.be. 2. White-Yellow Cross of Flanders, Brussels, Belgium. irina.dumitrescu@vlaanderen.wgk.be. 3. White-Yellow Cross of Flanders, Brussels, Belgium. 4. Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium. 5. Department of Nursing Science and Midwifery, Centre For Research and Innovation in Care (CRIC), Nurse and Pharmaceutical Care (NuPhaC), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Abstract
PURPOSE: To review the international literature related to high-risk medication (HRM) in community care, in order to (1) define a definition of HRM and (2) list the medication that is considered HRM in community care. METHODS: Scoping review: Five databases were systematically searched (MEDLINE, Scopus, CINAHL, Web Of Science, and Cochrane) and extended with a hand search of cited references. Two researchers reviewed the papers independently. All extracted definitions and lists of HRM were subjected to a self-developed quality appraisal. Data were extracted, analysed and summarised in tables. Critical attributes were extracted in order to analyse the definitions. RESULTS: Of the 109 papers retrieved, 36 met the inclusion criteria and were included in this review. Definitions for HRM in community care were used inconsistently among the papers, and various recurrent attributes of the concept HRM were used. Taking the recurrent attributes and the quality score of the definitions into account, the following definition could be derived: "High-risk medication are medications with an increased risk of significant harm to the patient. The consequences of this harm can be more serious than those with other medications". A total of 66 specific medications or categories were extracted from the papers. Opioids, insulin, warfarin, heparin, hypnotics and sedatives, chemotherapeutic agents (excluding hormonal agents), methotrexate and hypoglycaemic agents were the most common reported HRM in community care. CONCLUSION: The existing literature pertaining to HRM in community care was examined. The definitions and medicines reported as HRM in the literature are used inconsistently. We suggested a definition for more consistent use in future research and policy. Future research is needed to determine more precisely which definitions should be considered for HRM in community care.
PURPOSE: To review the international literature related to high-risk medication (HRM) in community care, in order to (1) define a definition of HRM and (2) list the medication that is considered HRM in community care. METHODS: Scoping review: Five databases were systematically searched (MEDLINE, Scopus, CINAHL, Web Of Science, and Cochrane) and extended with a hand search of cited references. Two researchers reviewed the papers independently. All extracted definitions and lists of HRM were subjected to a self-developed quality appraisal. Data were extracted, analysed and summarised in tables. Critical attributes were extracted in order to analyse the definitions. RESULTS: Of the 109 papers retrieved, 36 met the inclusion criteria and were included in this review. Definitions for HRM in community care were used inconsistently among the papers, and various recurrent attributes of the concept HRM were used. Taking the recurrent attributes and the quality score of the definitions into account, the following definition could be derived: "High-risk medication are medications with an increased risk of significant harm to the patient. The consequences of this harm can be more serious than those with other medications". A total of 66 specific medications or categories were extracted from the papers. Opioids, insulin, warfarin, heparin, hypnotics and sedatives, chemotherapeutic agents (excluding hormonal agents), methotrexate and hypoglycaemic agents were the most common reported HRM in community care. CONCLUSION: The existing literature pertaining to HRM in community care was examined. The definitions and medicines reported as HRM in the literature are used inconsistently. We suggested a definition for more consistent use in future research and policy. Future research is needed to determine more precisely which definitions should be considered for HRM in community care.
Entities:
Keywords:
Community care; Community health nurses; High-risk medication; Home care nurse; Medication care
Authors: Andrea M Wessell; Steven M Ornstein; Ruth G Jenkins; Lynne S Nemeth; Cara B Litvin; Paul J Nietert Journal: Am J Med Qual Date: 2012-06-07 Impact factor: 1.852
Authors: Jacqueline A Pugh; Chen-Pin Wang; Sara E Espinoza; Polly H Noël; Mary Bollinger; Megan Amuan; Erin Finley; Mary Jo Pugh Journal: J Am Geriatr Soc Date: 2014-01-21 Impact factor: 5.562
Authors: Arti Phatak; Rachael Prusi; Brooke Ward; Luke O Hansen; Mark V Williams; Elizabeth Vetter; Noelle Chapman; Michael Postelnick Journal: J Hosp Med Date: 2015-10-05 Impact factor: 2.960
Authors: Kristine E Ensrud; Terri L Blackwell; Carol M Mangione; Paula J Bowman; Mary A Whooley; Douglas C Bauer; Ann V Schwartz; Joseph T Hanlon; Michael C Nevitt Journal: J Am Geriatr Soc Date: 2002-10 Impact factor: 5.562
Authors: Lisa Kouladjian; Danijela Gnjidic; Emily Reeve; Timothy F Chen; Sarah N Hilmer Journal: Ann Pharmacother Date: 2016-06-01 Impact factor: 3.154